As TLR5 may play a pro-inflammatory and remodulatory role, further studies, both in vivo and in vitro, should be conducted to assess the potential for intervention in PAH therapy by modulating TLR5 function [113,114,115]. Here, TLR5 is linked to pulmonary arterial hypertension.